HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahanty, S. Articles by Pulendran, B. Search for Related Content PubMed PubMed Citation Articles by Mahanty, S. Articles by Pulendran, B.

Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses¹

Siddhartha Mahanty^2,*, Karen Hutchinson^*, Sudhanshu Agarwal, Michael Mcrae, Pierre E. Rollin^* and Bali Pulendran^2,

^* Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333; and Emory Vaccine Research Center and Department of Pathology, Emory University, Atlanta, GA 30329

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Acute infection of humans with Ebola and Lassa viruses, two principal etiologic agents of hemorrhagic fevers, often results in a paradoxical pattern of immune responses: early infection, characterized by an outpouring of inflammatory mediators such as TNF-, IL-1, and IL-6, vs late stage infections, which are associated with poor immune responses. The mechanisms underlying these diverse outcomes are poorly understood. In particular, the role played by cells of the innate immune system, such as dendritic cells (DC), is not known. In this study, we show that Ebola and Lassa viruses infect human monocyte-derived DC and impair their function. Monocyte-derived DC exposed to either virus fail to secrete proinflammatory cytokines, do not up-regulate costimulatory molecules, and are poor stimulators of T cells. These data represent the first evidence for a mechanism by which Ebola and Lassa viruses target DC to impair adaptive immunity.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Ebola virus, a member of the Filoviridae family, and Lassa virus, a member of the Arenaviridae family, represent two important etiological agents of viral hemorrhagic fevers (1, 2). Despite their disparate taxonomies, the diseases caused by both viruses share striking similarities, and are characterized by a rapidly progressive febrile illness with capillary leakage, often resulting in extensive mucosal and s.c. hemorrhage (3, 4). In its severe form, the illness frequently progresses to a septic shock-like syndrome with multisystem failure culminating in death. Careful studies of pathogenesis in infected humans have not been performed because of the remote location of human outbreaks and the accompanying lack of facilities for rigorous experimentation. Consequently, very little information is available about the cellular and molecular mechanisms that mediate the pathogenesis of these infections.

Data from in vitro experiments and animal models suggest that both Ebola and Lassa viruses infect macrophages and endothelial cells early in infection (5, 6, 7). Infection of these cell types, two principal players of the innate immune system, are believed to act as critical triggers for the rapid and uncontrolled secretion of inflammatory mediators (2, 3, 8, 9). However, despite the systemic release of inflammatory mediators that occurs following infection with Ebola or Lassa, severe or fatal diseases are often associated with a generalized suppression of adaptive immunity, as evidenced by the low specific Ab (3) and poor cellular immunity (8, 10). The cellular and molecular mechanisms that underlie these seemingly paradoxical immune states are unknown.

Dendritic cells (DC)³ occupy center stage as the most efficient APC in the immune system and are scattered throughout the body, including the portals of virus entry where they reside in an immature form (11, 12, 13, 14). Immature DC are capable of decoding and integrating signals from invading microbes and ferry this information to naive T cells in the secondary lymphoid organs, undergoing a maturation process en route. There, the mature DC present this information to T cells, thus launching an immune response. DC also play pivotal roles in modulating the strength and quality of the immune response (11, 12, 13, 14). Given these pivotal roles, there is an urgent need to understand how Ebola and Lassa viruses can manipulate DC functions to influence the outcome of these diseases. This information is of vital importance in understanding the pathogenesis of Ebola or Lassa and in devising novel therapeutic strategies. Our results show that these viruses readily infect and replicate in DC. In striking contrast to their effects on macrophages and endothelial cells (5, 6, 15), our data suggest that infection with either Ebola or Lassa viruses fails to activate DC, thereby interfering with their ability to initiate an adaptive immune response. Taken together, these data represent the first evidence for a mechanism by which Ebola and Lassa viruses target DC and Ag presentation to disarm the adaptive immune system and may offer an explanation for the immune suppression that is associated with these hemorrhagic fevers.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Viruses

A viral isolate (Mayinga strain, Vero E6, pass 2) from the 1976 outbreak of Ebola Zaire was used in these experiments. Ebola virions were purified by centrifugation of supernatants of Ebola-infected Vero E6 on a 20–60% sucrose gradient at 30,000 rpm for 16 h in a Ti-41 rotor (Beckman-Coulter, Fullerton, CA) (16). The band containing the concentrated virus was aspirated and washed twice by pelleting in PBS (30,000 rpm), titered by plaque assay, and stored in liquid nitrogen (17, 18). A Lassa virus (Niahun strain) stock was prepared by amplification of a human isolate from Sierra Leone on Vero E6 cells. After 14 days, the monolayer was then disrupted by freeze-thawing (four times), and the cell slurry was pelleted (10,000 rpm; 20 min) and aliquots of the supernatant containing the virus were stored in liquid nitrogen (18). Virus titers were determined by plaque assays. DC were infected at a multiplicity of infection (moi) of 1 (Ebola) or 0.5 (Lassa). Gamma-irradiated Ebola and Lassa aliquots were used as mock controls (5 x 10⁶ rad of gamma radiation).

Cell culture and in vitro infection with viruses

PBMC were obtained by aphresis from healthy human donors. Monocyte-derived DC (MDDC) were generated by standard methods as described previously (19). Briefly, CD14⁺ monocytes purified from blood PBMCs using mAbs and Dynabeads (Dynal Biotech, Norway) were cultured in six-well plates (1 x 10⁶/well) in RPMI 1640 (Life Technologies, Gaithersburg, MD) with 10% FBS (low endotoxin FCS; HyClone, Logan, UT) for 6 days in the presence of GM-CSF (100 ng/ml) and IL-4 (5 ng/ml; both from PeproTech, Rocky Hill, NJ) in a 5% CO₂ incubator as previously described (19). This resulted in enrichment for CD11c⁺CD1a⁺HLA-DR⁺ MDDC (>90%).

On day 6 of culture, immature MDDC were infected in vitro with either Ebola or Lassa virus (live or inactivated) by mixing virus stocks directly with pelleted aliquots of 0.5 x 10⁶ cells at the desired moi and incubation with rocking at 37°C for 45 min, followed by one wash in medium. Cells were then cultured at 0.5 x 10⁶ cells/ml in 48- or 96-well tissue culture plates (Corning, Corning, NY). Control cells were treated either with medium alone, or an equivalent doses of gamma-inactivated Ebola or Lassa virus or LPS (1–2 µg/ml Escherichia coli LPS; Sigma-Aldrich, St. Louis, MO). Supernatants and cells were harvested after 48 h of incubation at 37°C in 5% CO₂. All infections were done in the biosafety level 4 laboratory at the Centers for Disease Control and Prevention, and samples were gamma-irradiated before processing for other assays in a biosafety level 2 laboratory.

Phenotyping of DC cells

Activation of MDDC was evaluated by surface staining for CD86, CD80, or CD40. Briefly, after 48 h of incubation under various conditions, cells were washed twice with cold PBS (pH 7.2) containing 0.5% BSA (Sigma-Aldrich) (wash buffer) and incubated with fluorescent labeled Abs to CD11c, CD14, HLA-DR, and CD86 (BD PharMingen, San Diego, CA) for 30 min at 4°C. Cells were then washed and pelleted twice with wash buffer (1000 rpm) and fixed with 10% formalin for 4 days. Cells were then analyzed for surface expression of these markers by flow cytometry (FACSCalibur, BD Biosciences, San Jose, CA). Cells that were CD11c⁺HLA-DR⁺ were analyzed for expression of CD86, CD80, or CD40.

Immunofluorescent Ab staining for viral proteins

Infection of cells with Ebola or Lassa virus was confirmed by indirect immunofluorescence assays using reagents reported previously (18, 20). Viral proteins were detected by incubation with a pool of seven anti-Ebola mAbs (1:100 in PBS with 5% milk and 0.5% Tween 20) or rabbit polyclonal anti-Lassa serum (1:100 in the same buffer), followed by anti-mouse or anti-rabbit FITC conjugates (Bio-Rad, Hercules, CA) and examined under UV light for the presence of viral proteins.

Focus-forming unit assays

Virus was quantified in the supernatant of cells by a focus-forming unit assay as previously described (18). In brief, Vero E6 cells grown to confluence in 48-well plates were treated with serial 10-fold dilutions of cell supernatants (100 µl/well) for 45 min, with gentle rocking at 37°C. Methycellulose medium (final concentration: 1% in RPMI 1640 medium with 4% FCS; HyClone) was added, and a further incubation of 6 days followed. Cells were fixed with acetone/ethanol (95:5) and viral foci were detected by incubation with a pool of Ebola gp- and nuclear protein-specific mAbs (1:100) or Lassa-specific mouse hyperimmune ascitic fluid, followed by a HRP-conjugated anti-mouse IgG mAb (1:100; Bio-Rad) and a color substrate (True blue substrate; Kirkegaard & Perry Laboratories, Gaithersburg, MD). Foci were counted and data was expressed as focus-forming units (FFU) per milliliter.

Cytokine ELISAs

Cytokines levels in cell supernatants were measured in irradiated samples using a flow cytometric based assay developed in our laboratory as previously described (21). Abs against the cytokines were coupled to a single set of carboxylated microspheres using a two-step carbodiimide coupling procedure. Microsphere sets were mixed so that they would all be at approximately the same concentration. Two hundred microspheres were analyzed for each test. Samples (diluted 1/2 and 1/100) were added to duplicate wells of black flat-bottom half-well plates (Costar, Acton, MA). The plates were covered with adhesive foil and incubated for 1 h with constant agitation. Biotinylated Abs were diluted in storage buffer (PBS (pH 7.2), 1 mg/ml BSA-0.05% sodium azide) to a final concentration of 1 µg/ml (mAbs: IL-10, IL-8, TNF-, IFN-, IL-4, IL-6, and monocyte chemoattractant protein-1 (MCP-1)) or 5 µg/ml (polyclonal Abs: IL-1, macrophage-inflammatory protein (MIP)-1, MIP-1, and RANTES). Ten microliters of the Ab mix were added to each well, the foil cover was replaced, and the plate was incubated for 1 h with constant agitation. Streptavidin-conjugated PE was diluted in PBS-Tween to a final concentration of 5 µg/ml, and 100 µl was added to each well. Samples were analyzed on a Luminex 100 analyzer (Luminex, Austin, TX). Serial 3-fold dilutions of human recombinant cytokines were run on each plate to produce standard curves. Data was analyzed using PRISM analysis software (GraphPad, San Diego, CA).

Mixed lymphocyte reaction

Allogenic naive CD4⁺CD45RA⁺ T cells were purified using the MACS CD4⁺ T cell isolation kit (Miltenyi Biotec, Auburn, CA). MDDC incubated in various conditions for 48 h were mixed in 96-well plates with various DC:T cell ratios. Cells were cultured at 37°C with 5% CO₂ for 4 days and pulsed with [³H]thymidine (1 µCi/well; NEN, Boston, MA) for 16 h. Plates were gamma-irradiated in wet ice, and cells therein were harvested onto glass fiber filters (Skatron 11055 Micro96 cell harvester; Molecular Devices, Sunnyvale, CA); retained radioactivity quantitated in a beta counter (PerkinElmer Life Sciences, Boston, MA) was converted to cpm for comparison between samples.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Ebola and Lassa viruses infect human MDDC

After 6 days of culture with GM-CSF and IL-4, immature MDDC constituted >90% of the cell population (data not shown). As reported previously (19), these cells were characteristically CD1a⁺, HLA-DR⁺, CD14^-, CD80^dull, and CD86^dull (data not shown). To determine whether Ebola and Lassa viruses could productively infect human MDDC, they were infected in vitro with either Ebola or Lassa virus (live or inactivated). The survival of DC as various times after infection was determined by trypan blue staining (Fig. 1A). Neither Ebola nor Lassa viruses caused significant cell death in the first 4 days of culture (Fig. 1A). After 4 days, 20–30% of cells were dead as determined by trypan blue staining. Immunofluorescence assays for viral proteins (Ebola gp, nuclear protein, and viral protein 40, and all Lassa viral proteins) demonstrated that both Ebola and Lassa had infected significant numbers of MDDC by 48 h (Fig. 1B). Furthermore, quantitation of the viruses in supernatants of MDDC at 48 h by plaque assays confirmed that both Ebola and Lassa virus established productive infections with increasing viral titers: an increase of 3 logs in Ebola titers (from log titer 4.0 at the start of culture to 7.1) and 1.5 log in Lassa viral titers over the amount of virus used in infection (from log titer 4.0 at the start of culture to 5.5) (Fig. 1C). These results indicate that Ebola and Lassa viruses can infect and replicate within MDDC and are therefore capable of directly interfering with cellular function.

View larger version (42K): [in this window] [in a new window]   FIGURE 1. Infection of MDDC by Ebola and Lassa viruses. A, Survival of MDDC following Ebola and Lassa virus infection. MDDC (1 x 106 cells) were infected with Ebola or Lassa virus and cultured at 37°C for 6 days. Surviving cells were enumerated by trypan blue exclusion and survival (%) were calculated on days 2, 4, and 6. Inactivated Ebola and Lassa virus, at the same moi, were used as controls. Bars represent the means of two replicate wells, and the error bars represent the SEM. Med, Uninfected cells. B, Immunofluorescence assay showing infection of MDDC by Ebola and Lassa viruses. MDDC cultured with live or inactivated Ebola or Lassa virus for 48 h were fixed with cold acetone, and viral Ags were detected using a pool of monoclonal (for Ebola) or polyclonal Abs (Lassa) (see Materials and Methods) followed by FITC-labeled anti-IgG conjugates. The left upper and lower panels are infected MDDC incubated with normal mouse (for Ebola) or rabbit (Lassa) sera as negative controls. C, Viral replication in MDDC. Live virus was quantified in 48-h cell supernatants of MDDC infected with Ebola or Lassa virus (or inactivated virus as controls) by focus-forming assays. The bar labeled "Start" is the titer of the live virus used to infect each well at the beginning of culture. Bars represent the means of three wells and the error bars represent the SEM.

Given that Ebola and Lassa viruses can infect MDDC, we were interested in determining whether this resulted in alteration of MDDC function. To address this question, we measured the secretion of inflammatory cytokines and chemokines by MDDC following infection with Ebola and Lassa viruses. In addition to TNF-, IL-, IL-6, and IFN-, cytokines that have been proposed to play a crucial role in the inflammation following infection with Ebola (21, 22) and Lassa (6, 9) viruses, we also measured the secretion of IL-8, MIP-1, MIP-1, and MCP-1, chemokines that are likely to be involved in recruitment of macrophages, neutrophils, and T cells. The interaction of DC with diverse microbial stimuli, such as LPSs, CpG bacterial DNA, or viral heat shock proteins is known to induce the production of several proinflammatory cytokines (11, 12, 13, 14). Unexpectedly, we found that MDDC infected or stimulated by either live or killed Ebola and Lassa viruses did not secrete TNF-, IL-1, IL-6, IL-10 (Fig. 2A), or IL-2, IFN-, or IL-12 (data not shown), as would be expected after a typical inflammatory stimulus, such as LPS (14). This effect on MDDC is in striking contrast to the effect of these viruses on macrophages (5, 6), and to the effects of other viruses such as dengue (23, 24) on DC, although several viruses such as the measles virus has been shown to inhibit DC function in a similar manner (25, 26). Interestingly, the secretion of certain chemokines (notably IL-8 and MCP-1) was significantly higher with Ebola or Lassa virus, compared with LPS (Fig. 2A), suggesting a selective negative effect of these viruses on the induction of the proinflammatory cytokines.

View larger version (36K): [in this window] [in a new window]   FIGURE 2. Secretion of inflammatory and anti-inflammatory mediators and activation of MDDC in response to Ebola and Lassa viruses. A, Cytokine and chemokine secretion by MDDC (0.5 x 106 cells) cultured for 48 h with live or inactivated Ebola or Lassa viruses, or LPS (1 µg/ml). B, Expression of the costimulatory molecules CD86, CD80, and CD40 on MDDC following Ebola and Lassa virus infection. MFI, Mean fluorescence index.

Ebola and Lassa viruses impair MDDC-mediated adaptive immunity

The initiation of an adaptive immune response to an invading pathogen is a critical function of DC (11, 12, 13, 14). To determine whether, in these experiments, failure of Ebola and Lassa viruses to induce proinflammatory cytokines and costimulatory molecules on DC had direct consequences on the induction of adaptive immunity, we examined the effect of infection with Ebola and Lassa on their ability to induce the proliferation of naive CD4⁺CD45RA⁺ T cells in an MLR. As seen in Fig. 3, DC infected with live Ebola or Lassa viruses fail to induce the proliferation of allogenic T cells. In fact, the level of proliferation induced by such DC is even lower than that observed with unstimulated DC. In contrast, DC matured with LPS elicit significant levels of proliferation, as observed previously (11, 12, 13, 14).

View larger version (20K): [in this window] [in a new window]   FIGURE 3. Impaired function of DC infected with Ebola or Lassa virus. DC were infected with Ebola or Lassa, washed, and then cultured with naive, allogeneic CD4+ T cells for 5 days. Uptake of [3H]thymidine is shown in the graph as cpm on the y-axis, and MDDC pretreatment condition is shown on the x-axis. Bars and error bars represent the means of quadruplicate cultures from each of four donors and the SEM. TC, T cells alone; Med, medium.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
Systemic release of inflammatory mediators has been considered to be the hallmark of viral hemorrhagic fevers (7, 8, 9, 21, 27). Much of the data supporting a critical role for inflammatory cells has come from studies of macrophages, one of the early targets of viral replication for both Ebola and Lassa. Interactions between Lassa virus and DC have not been reported to date, and although Ebola virus has been shown to be capable of infecting APC (28), the consequence of such infection for DC function and adaptive immunity is a mystery. Therefore, the present data is, to our knowledge, the first to demonstrate that infection of DC with either Ebola or Lassa results in immune suppression. Notably, earlier studies on survivors of acute Lassa virus infection indicated that there was a considerable lag before the detection of neutralizing Abs and T cells responses (3), but the mechanisms that mediate this delay are not known.

These observations contrast sharply with the strong activation of macrophages and endothelial cells reported by several investigators (5, 6, 15). One implication of our data is that these viruses may differentially regulate the inflammatory responses in different cell populations or microenvironments within the host. Because DC are critical for Ag presentation, down-regulation of DC function may contribute to the immune suppression observed in Ebola and Lassa infections.

The failure of DC exposed to Ebola or Lassa viruses to efficiently stimulate T cells either may be attributed to an active suppression of DC function by the viruses or may reflect lack of maturation of the DC, presumably due to the absence of a maturation signal from the viruses. However, the ability of both viruses to induce abundant levels of MIP-1 strongly suggests that the viruses are indeed exerting potent effects on the DC and that the absence of TNF- and other proinflammatory cytokines is more likely to be due to a selective inhibition (or lack of activation) of the signaling pathway mediating the production of proinflammatory cytokines. In this context, our preliminary data suggest that the inhibitory effects of Ebola, but not Lassa virus, can be overcome by LPS stimulation of DC (data not shown). The mechanism of this difference is clearly an area that deserves attention. Finally, understanding the mechanisms by which either Ebola or Lassa viruses fail to activate DC and adaptive immunity may identify novel strategies of augmenting immune responses in the treatment of viral hemorrhagic fevers.

	Acknowledgments

 
We acknowledge Dr. Thomas Ksiazek for providing the monoclonal and polyclonal Abs against Ebola and Lassa viruses used in immunofluorescence assays. We thank John O’Connor for his excellent editorial comments.

	Footnotes

 
¹ This work was partly supported by National Institutes of Health Grants DK 57665-01 and AI 48638-01 to B.P.

² Address correspondence and reprint requests to Dr. Siddhartha Mahanty, Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop G14, Atlanta, GA 30333; or Dr. Bali Pulendran, Emory Vaccine Center, 954 Gatewood Road, Atlanta, GA 30329. E-mail addresses: smahanty{at}cdc.gov or bpulend{at}rmy.emory.edu

³ Abbreviations used in this paper: DC, dendritic cell; MDDC, monocyte-derived DC; moi, multiplicity of infection; MCP-1, monocyte chemoattractant protein-1; MIP, macrophage-inflammatory protein.

Received for publication October 30, 2002. Accepted for publication January 23, 2003.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Nichol, S. T., J. Arikawa, Y. Kawaoka. 2000. Emerging viral diseases. Proc. Natl. Acad. Sci. USA 97:12411.[Free Full Text]
2. Peters, C. J., J. W. LeDuc. 1999. An introduction to Ebola: the virus and the disease. J. Infect. Dis. 179:(Suppl. 1):ix.
3. McCormick, J. B., S. P. Fisher-Hoch. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75.[Medline]
4. Sanchez, A. S., A. S. Khan, S. R. Zaki, G. J. Nabel, T. G. Ksiazek, C. J. Peters. 2001. Filoviridae: Marburg and Ebola viruses: pathology and pathogenesis. D. M. Knipe, and P. M. Howley, eds. In Field’s Virology Vol. 1:1293. Lippincott Williams and Wilkins, Philadelphia.
5. Gupta, M., S. Mahanty, R. Ahmed, P. E. Rollin. 2001. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1 and TNF- and inhibit poly-IC-induced IFN- in vitro. Virology 284:20.[Medline]
6. Lukashevich, I. S., R. Maryankova, A. S. Vladyko, N. Nashkevich, S. Koleda, M. Djavani, D. Horejsh, N. N. Voitenok, M. S. Salvato. 1999. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF- gene expression. J. Med. Virol. 59:552.[Medline]
7. Schnittler, H. J., H. Feldmann. 1999. Molecular pathogenesis of filovirus infections: role of macrophages and endothelial cells. Curr. Top. Microbiol. Immunol. 235:175.[Medline]
8. Villinger, F., P. E. Rollin, S. S. Brar, N. F. Chikkala, J. Winter, J. B. Sundstrom, S. R. Zaki, R. Swanepoel, A. A. Ansari, C. J. Peters. 1999. Markedly elevated levels of interferon (IFN)-, IFN-, interleukin (IL)-2, IL-10, and tumor necrosis factor- associated with fatal Ebola virus infection. J. Infect. Dis. 179:(Suppl. 1):S188.
9. Mahanty, S., D. G. Bausch, R. L. Thomas, A. Goba, A. Bah, C. J. Peters, P. E. Rollin. 2001. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J. Infect. Dis. 183:1713.[Medline]
10. Leroy, E. M., S. Baize, V. E. Volchkov, S. P. Fisher-Hoch, M.-C. Georges-Courbot, J. Lansoud-Soukate, M. Capron, P. Debré, J. B. McCormick, A. J. Georges. 2000. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355:2210.[Medline]
11. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.[Medline]
12. Liu, Y. J.. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259.[Medline]
13. Pulendran, B., K. Palucka, J. Banchereau. 2001. Sensing pathogens and tuning immune responses. Science 293:253.[Abstract/Free Full Text]
14. Rescigno, M.. 2002. Dendritic cells and the complexity of microbial infection. Trends Microbiol. 10:425.[Medline]
15. Stroher, U., E. West, H. Bugany, H. D. Klenk, H. J. Schnittler, H. Feldmann. 2001. Infection and activation of monocytes by Marburg and Ebola viruses. J. Virol. 75:11025.[Abstract/Free Full Text]
16. Sanchez, A., Z. Y. Yang, L. Xu, G. J. Nabel, T. Crews, C. J. Peters. 1998. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72:6442.[Abstract/Free Full Text]
17. Tomori, O., K. M. Johnson, M. P. Kiley, L. H. Elliott. 1987. Standardization of a plaque assay for Lassa virus. J. Med. Virol. 22:77.[Medline]
18. Ksiazek, T. G., P. E. Rollin, A. J. Williams, D. S. Bressler, M. L. Martin, R. Swanepoel, F. J. Burt, P. A. Leman, A. S. Khan, A. K. Rowe, et al 1999. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179:(Suppl. 1):S177.
19. Mailliard, R. B., S. Egawa, Q. Cai, A. Kalinska, S. N. Bykovskaya, M. T. Lotze, M. L. Kapsenberg, W. J. Storkus, P. Kalinski. 2002. Complementary dendritic cell-activating function of CD8⁺ and CD4⁺ T cells: helper role of CD8⁺ T cells in the development of T helper type 1 responses. J. Exp. Med. 195:473.[Abstract/Free Full Text]
20. Bausch, D. G., P. E. Rollin, A. H. Demby, M. Coulibaly, J. Kanu, A. S. Conteh, K. D. Wagoner, L. K. McMullan, M. D. Bowen, C. J. Peters, T. G. Ksiazek. 2000. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J. Clin. Microbiol. 38:2670.[Abstract/Free Full Text]
21. Hutchinson, K. L., F. Villinger, M. E. Miranda, T. G. Ksiazek, C. J. Peters, P. E. Rollin. 2001. Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype). J. Med. Virol. 65:561.[Medline]
22. Baize, S., E. M. Leroy, A. J. Georges, M. C. Georges-Courbot, M. Capron, I. Bedjabaga, J. Lansoud-Soukate, E. Mavoungou. 2002. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 128:163.[Medline]
23. Ho, L. J., J. J. Wang, M. F. Shaio, C. L. Kao, D. M. Chang, S. W. Han, J. H. Lai. 2001. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166:1499.[Abstract/Free Full Text]
24. Libraty, D. H., S. Pichyangkul, C. Ajariyakhajorn, T. P. Endy, F. A. Ennis. 2001. Human dendritic cells are activated by dengue virus infection: enhancement by -interferon and implications for disease pathogenesis. J. Virol. 75:3501.[Abstract/Free Full Text]
25. Grosjean, I., C. Caux, C. Bella, I. Berger, F. Wild, J. Banchereau, D. Kaiserlian. 1997. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4⁺ T cells. J. Exp. Med. 186:801.[Abstract/Free Full Text]
26. Fugier-Vivier, I., C. Servet-Delprat, P. Rivailler, M. C. Rissoan, Y. J. Liu, C. Rabourdin-Combe. 1997. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:813.[Abstract/Free Full Text]
27. Fisher-Hoch, S. P., J. B. McCormick. 1987. Pathophysiology and treatment of Lassa fever. Curr. Top. Microbiol. Immunol. 134:231.[Medline]
28. Gibb, T. R., D. A. Norwood, Jr., N. Woollen, E. A. Henchal. 2002. Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain). Clin. Diagn. Lab. Immunol. 9:19.[Abstract/Free Full Text]

This article has been cited by other articles:

				L. F. Zhang, K. Okuma, R. Tanaka, A. Kodama, K. Kondo, A. A. Ansari, and Y. Tanaka Generation of Mature Dendritic Cells with Unique Phenotype and Function by In Vitro Short-Term Culture of Human Monocytes in the Presence of Interleukin-4 and Interferon-{beta} Experimental Biology and Medicine, June 1, 2008; 233(6): 721 - 731. [Abstract] [Full Text] [PDF]

				S. B. Bradfute, K. L. Warfield, and S. Bavari Functional CD8+ T Cell Responses in Lethal Ebola Virus Infection J. Immunol., March 15, 2008; 180(6): 4058 - 4066. [Abstract] [Full Text] [PDF]

				St. P. Reid, C. Valmas, O. Martinez, F. M. Sanchez, and C. F. Basler Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin {alpha} Proteins with Activated STAT1 J. Virol., December 15, 2007; 81(24): 13469 - 13477. [Abstract] [Full Text] [PDF]

				A. Thitithanyanont, A. Engering, P. Ekchariyawat, S. Wiboon-ut, A. Limsalakpetch, K. Yongvanitchit, U. Kum-Arb, W. Kanchongkittiphon, P. Utaisincharoen, S. Sirisinha, et al. High Susceptibility of Human Dendritic Cells to Avian Influenza H5N1 Virus Infection and Protection by IFN-{alpha} and TLR Ligands J. Immunol., October 15, 2007; 179(8): 5220 - 5227. [Abstract] [Full Text] [PDF]

				R. Carrion Jr., K. Brasky, K. Mansfield, C. Johnson, M. Gonzales, A. Ticer, I. Lukashevich, S. Tardif, and J. Patterson Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues J. Virol., June 15, 2007; 81(12): 6482 - 6490. [Abstract] [Full Text] [PDF]

				S. Muller, R. Geffers, and S. Gunther Analysis of gene expression in Lassa virus-infected HuH-7 cells J. Gen. Virol., May 1, 2007; 88(5): 1568 - 1575. [Abstract] [Full Text] [PDF]

				N. L. Yonkers, B. Rodriguez, K. A. Milkovich, R. Asaad, M. M. Lederman, P. S. Heeger, and D. D. Anthony TLR Ligand-Dependent Activation of Naive CD4 T Cells by Plasmacytoid Dendritic Cells Is Impaired in Hepatitis C Virus Infection J. Immunol., April 1, 2007; 178(7): 4436 - 4444. [Abstract] [Full Text] [PDF]

				C. M. Bosio, H. Bielefeldt-Ohmann, and J. T. Belisle Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu4 J. Immunol., April 1, 2007; 178(7): 4538 - 4547. [Abstract] [Full Text] [PDF]

				G. C. Bowick, S. M. Fennewald, E. P. Scott, L. Zhang, B. L. Elsom, J. F. Aronson, H. M. Spratt, B. A. Luxon, D. G. Gorenstein, and N. K. Herzog Identification of Differentially Activated Cell-Signaling Networks Associated with Pichinde Virus Pathogenesis by Using Systems Kinomics J. Virol., February 15, 2007; 81(4): 1923 - 1933. [Abstract] [Full Text] [PDF]

				Z. Feng, M. Cerveny, Z. Yan, and B. He The VP35 Protein of Ebola Virus Inhibits the Antiviral Effect Mediated by Double-Stranded RNA-Dependent Protein Kinase PKR J. Virol., January 1, 2007; 81(1): 182 - 192. [Abstract] [Full Text] [PDF]

				K. Yaddanapudi, G. Palacios, J. S. Towner, I. Chen, C. A. Sariol, S. T. Nichol, and W. I. Lipkin Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses FASEB J, December 1, 2006; 20(14): 2519 - 2530. [Abstract] [Full Text] [PDF]

				P. Sun, C. M. Celluzzi, M. Marovich, H. Subramanian, M. Eller, S. Widjaja, D. Palmer, K. Porter, W. Sun, and T. Burgess CD40 Ligand Enhances Dengue Viral Infection of Dendritic Cells: A Possible Mechanism for T Cell-Mediated Immunopathology J. Immunol., November 1, 2006; 177(9): 6497 - 6503. [Abstract] [Full Text] [PDF]

				G. C. Bowick, S. M. Fennewald, B. L. Elsom, J. F. Aronson, B. A. Luxon, D. G. Gorenstein, and N. K. Herzog Differential signaling networks induced by mild and lethal hemorrhagic Fever virus infections. J. Virol., October 1, 2006; 80(20): 10248 - 10252. [Abstract] [Full Text] [PDF]

				M. Mohamadzadeh, S. S. Coberley, G. G. Olinger, W. V. Kalina, G. Ruthel, C. L. Fuller, D. L. Swenson, W. D. Pratt, D. B. Kuhns, and A. L. Schmaljohn Activation of Triggering Receptor Expressed on Myeloid Cells-1 on Human Neutrophils by Marburg and Ebola Viruses J. Virol., July 15, 2006; 80(14): 7235 - 7244. [Abstract] [Full Text] [PDF]

				A. L. Hartman, J. E. Dover, J. S. Towner, and S. T. Nichol Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or Replication. J. Virol., July 1, 2006; 80(13): 6430 - 6440. [Abstract] [Full Text] [PDF]

				St. P. Reid, L. W. Leung, A. L. Hartman, O. Martinez, M. L. Shaw, C. Carbonnelle, V. E. Volchkov, S. T. Nichol, and C. F. Basler Ebola Virus VP24 Binds Karyopherin {alpha}1 and Blocks STAT1 Nuclear Accumulation. J. Virol., June 1, 2006; 80(11): 5156 - 5167. [Abstract] [Full Text] [PDF]

				J. C. Kash, E. Muhlberger, V. Carter, M. Grosch, O. Perwitasari, S. C. Proll, M. J. Thomas, F. Weber, H.-D. Klenk, and M. G. Katze Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence J. Virol., March 15, 2006; 80(6): 3009 - 3020. [Abstract] [Full Text] [PDF]

				A. Bukreyev, L. Yang, S. R. Zaki, W.-J. Shieh, P. E. Rollin, B. R. Murphy, P. L. Collins, and A. Sanchez A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus Challenge J. Virol., March 1, 2006; 80(5): 2267 - 2279. [Abstract] [Full Text] [PDF]

				S. Kunz, J. M. Rojek, M. Kanagawa, C. F. Spiropoulou, R. Barresi, K. P. Campbell, and M. B. A. Oldstone Posttranslational Modification of {alpha}-Dystroglycan, the Cellular Receptor for Arenaviruses, by the Glycosyltransferase LARGE Is Critical for Virus Binding J. Virol., November 15, 2005; 79(22): 14282 - 14296. [Abstract] [Full Text] [PDF]

				C. M. Bosio and S. W. Dow Francisella tularensis Induces Aberrant Activation of Pulmonary Dendritic Cells J. Immunol., November 15, 2005; 175(10): 6792 - 6801. [Abstract] [Full Text] [PDF]

				E. Flano, B. Kayhan, D. L. Woodland, and M. A. Blackman Infection of Dendritic Cells by a {gamma}2-Herpesvirus Induces Functional Modulation J. Immunol., September 1, 2005; 175(5): 3225 - 3234. [Abstract] [Full Text] [PDF]

				S. Kunz, J. M. Rojek, M. Perez, C. F. Spiropoulou, and M. B. A. Oldstone Characterization of the Interaction of Lassa Fever Virus with Its Cellular Receptor {alpha}-Dystroglycan J. Virol., May 15, 2005; 79(10): 5979 - 5987. [Abstract] [Full Text] [PDF]

				A. Sanchez, M. Lukwiya, D. Bausch, S. Mahanty, A. J. Sanchez, K. D. Wagoner, and P. E. Rollin Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide Levels J. Virol., October 1, 2004; 78(19): 10370 - 10377. [Abstract] [Full Text] [PDF]

				D. Pannetier, C. Faure, M.-C. Georges-Courbot, V. Deubel, and S. Baize Human Macrophages, but Not Dendritic Cells, Are Activated and Produce Alpha/Beta Interferons in Response to Mopeia Virus Infection J. Virol., October 1, 2004; 78(19): 10516 - 10524. [Abstract] [Full Text] [PDF]

				L. Fantuzzi, C. Purificato, K. Donato, F. Belardelli, and S. Gessani Human Immunodeficiency Virus Type 1 gp120 Induces Abnormal Maturation and Functional Alterations of Dendritic Cells: a Novel Mechanism for AIDS Pathogenesis J. Virol., September 15, 2004; 78(18): 9763 - 9772. [Abstract] [Full Text] [PDF]

				W. G. Glass, K. Subbarao, B. Murphy, and P. M. Murphy Mechanisms of Host Defense following Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Pulmonary Infection of Mice J. Immunol., September 15, 2004; 173(6): 4030 - 4039. [Abstract] [Full Text] [PDF]

				K. L. Warfield, J. G. Perkins, D. L. Swenson, E. M. Deal, C. M. Bosio, M. J. Aman, W. M. Yokoyama, H. A. Young, and S. Bavari Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection J. Exp. Med., July 19, 2004; 200(2): 169 - 179. [Abstract] [Full Text] [PDF]

				A. Granelli-Piperno, A. Golebiowska, C. Trumpfheller, F. P. Siegal, and R. M. Steinman HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation PNAS, May 18, 2004; 101(20): 7669 - 7674. [Abstract] [Full Text] [PDF]

				S. Baize, J. Kaplon, C. Faure, D. Pannetier, M.-C. Georges-Courbot, and V. Deubel Lassa Virus Infection of Human Dendritic Cells and Macrophages Is Productive but Fails to Activate Cells J. Immunol., March 1, 2004; 172(5): 2861 - 2869. [Abstract] [Full Text] [PDF]

				K. L. Warfield, C. M. Bosio, B. C. Welcher, E. M. Deal, M. Mohamadzadeh, A. Schmaljohn, M. J. Aman, and S. Bavari Ebola virus-like particles protect from lethal Ebola virus infection PNAS, December 23, 2003; 100(26): 15889 - 15894. [Abstract] [Full Text] [PDF]